Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MRK

Merck

$63.57

-0.34 (-0.53%)

16:06
03/22/17
03/22
16:06
03/22/17
16:06
Hot Stocks
Breaking Hot Stocks news story on Merck »

Merck Animal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Mar

  • 24

    Mar

  • 27

    Mar

  • 01

    Apr

  • 10

    May

  • 27

    May

  • 09

    Jun

  • 14

    Jun

ADRO

Aduro Biotech

$10.35

-1.05 (-9.21%)

, ADXS

Advaxis

$7.82

-0.69 (-8.11%)

15:45
03/22/17
03/22
15:45
03/22/17
15:45
Conference/Events
Piper Jaffray biopharma analyst holds an analyst/industry conference call »

Biopharmaceuticals…

ADRO

Aduro Biotech

$10.35

-1.05 (-9.21%)

ADXS

Advaxis

$7.82

-0.69 (-8.11%)

AMGN

Amgen

$166.85

-2.39 (-1.41%)

CELG

Celgene

$123.82

-2.69 (-2.13%)

DVAX

Dynavax

$5.65

-0.35 (-5.83%)

IMDZ

Immune Design

$6.55

-0.65 (-9.03%)

MRK

Merck

$63.61

-0.3 (-0.47%)

NKTR

Nektar

$21.83

-0.28 (-1.27%)

ONCS

OncoSec

$1.29

0.02 (1.57%)

PFE

Pfizer

$34.43

0.1801 (0.53%)

RHHBY

Roche

$31.41

-0.21 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

  • 24

    Mar

  • 27

    Mar

  • 27

    Mar

  • 29

    Mar

  • 31

    Mar

  • 01

    Apr

  • 02

    May

  • 10

    May

  • 27

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

  • 26

    Jun

  • 19

    Jul

  • 10

    Aug

  • 27

    Aug

ABBV

AbbVie

$65.31

-0.04 (-0.06%)

13:39
03/22/17
03/22
13:39
03/22/17
13:39
Upgrade
AbbVie rating change at Societe Generale »

AbbVie upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 06

    Jun

CTRV

ContraVir Pharmaceuticals

$1.57

-0.0801 (-4.85%)

11:22
03/22/17
03/22
11:22
03/22/17
11:22
Conference/Events
ContraVir Pharmaceuticals management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

ADAP

Adaptimmune

$4.29

-0.33 (-7.14%)

, BLCM

Bellicum Pharmaceuticals

$13.91

-1.36 (-8.91%)

10:25
03/22/17
03/22
10:25
03/22/17
10:25
Conference/Events
Piper Jaffray biopharma analyst holds an analyst/industry conference call »

Biopharma Analyst…

ADAP

Adaptimmune

$4.29

-0.33 (-7.14%)

BLCM

Bellicum Pharmaceuticals

$13.91

-1.36 (-8.91%)

CELG

Celgene

$123.82

-2.69 (-2.13%)

CLLS

Cellectis

$23.31

-1.06 (-4.35%)

CMRX

Chimerix

$6.00

-0.19 (-3.07%)

JUNO

Juno Therapeutics

$20.68

-2.17 (-9.50%)

KITE

Kite Pharma

$76.67

-8.27 (-9.74%)

MRK

Merck

$63.35

-0.56 (-0.88%)

NVS

Novartis

$73.99

-0.4 (-0.54%)

SHPG

Shire

$173.14

-3.05 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

  • 27

    Mar

  • 01

    Apr

  • 10

    May

  • 27

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

  • 26

    Jun

  • 22

    Mar

LLY

Eli Lilly

$84.37

0.64 (0.76%)

09:55
03/22/17
03/22
09:55
03/22/17
09:55
Conference/Events
Eli Lilly participates in a conference call hosted by Bernstein »

Bernstein Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 27

    Mar

  • 19

    Apr

AVEO

AVEO Oncology

$0.84

-0.0098 (-1.15%)

, BMY

Bristol-Myers

$55.71

-0.7 (-1.24%)

07:01
03/22/17
03/22
07:01
03/22/17
07:01
Hot Stocks
AVEO announces first patient dosed in Phase 1/2 trial of tivozanib, opdivo »

AVEO Oncology (AVEO)…

AVEO

AVEO Oncology

$0.84

-0.0098 (-1.15%)

BMY

Bristol-Myers

$55.71

-0.7 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Apr

  • 27

    Apr

  • 06

    Jun

NVS

Novartis

$74.39

-1.29 (-1.70%)

06:24
03/22/17
03/22
06:24
03/22/17
06:24
Hot Stocks
Novartis says serelaxin did not meet primary endpoint in RELAX-AHF-2 study »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 26

    Jun

JNJ

Johnson & Johnson

$127.25

-0.82 (-0.64%)

, LLY

Eli Lilly

$83.73

-0.33 (-0.39%)

04:55
03/22/17
03/22
04:55
03/22/17
04:55
Conference/Events
Biotech Industry Organization and EBD Group to host a conference »

11th Annual BIO-Europe…

JNJ

Johnson & Johnson

$127.25

-0.82 (-0.64%)

LLY

Eli Lilly

$83.73

-0.33 (-0.39%)

MRK

Merck

$63.91

-0.2 (-0.31%)

CTRV

ContraVir Pharmaceuticals

$1.57

-0.0801 (-4.85%)

BIIB

Biogen

$275.79

0.99 (0.36%)

DNA

Bought by RHHBY

AMGN

Amgen

$166.85

-2.39 (-1.41%)

BMY

Bristol-Myers

$55.71

-0.7 (-1.24%)

ABBV

AbbVie

$65.35

-0.45 (-0.68%)

RHHBY

Roche

$31.41

-0.21 (-0.66%)

SNY

Sanofi

$44.36

-0.15 (-0.34%)

BAYRY

Bayer

$113.53

-0.7025 (-0.61%)

PFE

Pfizer

$34.25

-0.13 (-0.38%)

NVS

Novartis

$74.39

-1.29 (-1.70%)

PTHN

Patheon

$26.38

-0.41 (-1.53%)

PM

Philip Morris

$113.49

0.52 (0.46%)

RDHL

RedHill Biopharma

$10.37

-0.05 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 01

    Apr

  • 19

    Apr

  • 27

    Apr

  • 27

    Apr

  • 10

    May

  • 27

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

  • 26

    Jun

  • 19

    Jul

  • 27

    Aug

LLY

Eli Lilly

$83.73

-0.33 (-0.39%)

04:55
03/22/17
03/22
04:55
03/22/17
04:55
Conference/Events
Eli Lilly participates in a conference call hosted by Bernstein »

Bernstein Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 27

    Mar

  • 19

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.